Sparrow Pharmaceuticals Secures $50 Million Series A Financing Names Industry Veteran Robert Jacks as President & CEO

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3otveQU
via IFTTT